title: Cancer gene discovery in hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is a deadly cancer, whose incidence is increasing worldwide. Albeit the main risk factors for HCC development have been clearly identified, such as hepatitis B and C virus infection and alcohol abuse, there is still preliminary understanding of the key drivers of this malignancy. Recent data suggest that genomic analysis of cirrhotic tissue - the pre-neoplastic carcinogenic field - may provide a read-out to identify at risk populations for cancer development. Given this contextual complexity, it is of utmost importance to characterize the molecular pathogenesis of this disease, and pinpoint the dominant pathways/drivers by integrative oncogenomic approaches and/or sophisticated experimental models. Identification of the dominant proliferative signals and key aberrations will allow for a more personalized therapy. Pathway-based approaches and functional experimental studies have aided in identifying the activation of different signaling cascades in HCC (e.g. epidermal growth factor, insulin-like growth factor, RAS, MTOR, WNT-betacatenin, etc.). However, the introduction of new high-throughput genomic technologies (e.g. microarrays, deep sequencing, etc.), and increased sophistication of computational biology (e.g. bioinformatics, biomodeling, etc.), opens the field to new strategies in oncogene and tumor suppressor discovery. These oncogenomic approaches are framed within emerging new disciplines such as systems biology, which integrates multiple inputs to explain cancer onset and progression. In addition, the consolidation of sophisticated animal models, such as mosaic cancer mouse models or the use of transposons for mutagenesis screens, have been instrumental for the identification of novel tumor drivers. We herein review some classical as well as some recent fast track approaches for oncogene discovery in HCC, and provide a comprehensive landscape of the currently known spectrum of molecular aberrations involved in hepatocarcinogenesis.
authors.affiliation: Helmholtz Centre for Infection Research, Braunschweig 38124, Germany.
authors.forename: Lars
authors.initials: L
authors.lastname: Zender
authors.forename: Augusto
authors.initials: A
authors.lastname: Villanueva
authors.forename: Victoria
authors.initials: V
authors.lastname: Tovar
authors.forename: Daniela
authors.initials: D
authors.lastname: Sia
authors.forename: Derek Y
authors.initials: DY
authors.lastname: Chiang
authors.forename: Josep M
authors.initials: JM
authors.lastname: Llovet
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000378:metabolism; D004195:Disease Models, Animal; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D015398:Signal Transduction / Q000235:genetics*
references.citation: N Engl J Med. 2008 Jul 24;359(4):378-90
references.pmid: 18650514
references.citation: Oncogene. 2002 Mar 14;21(12):1791-9
references.pmid: 11896611
references.citation: Nature. 2004 Oct 28;431(7012):1112-7
references.pmid: 15475948
references.citation: N Engl J Med. 2009 Oct 8;361(15):1437-47
references.pmid: 19812400
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: Blood. 1998 Nov 15;92(10):3780-92
references.pmid: 9808572
references.citation: Gastroenterology. 2009 Jan;136(1):138-48
references.pmid: 18848939
references.citation: FEBS J. 2006 Mar;273(6):1102-14
references.pmid: 16519677
references.citation: Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4171-7
references.pmid: 16857788
references.citation: Oncogene. 1995 Feb 16;10(4):765-8
references.pmid: 7862454
references.citation: Cancer Res. 2004 Jan 1;64(1):48-54
references.pmid: 14729607
references.citation: Gastroenterology. 2006 Apr;130(4):1117-28
references.pmid: 16618406
references.citation: Nature. 2004 Nov 18;432(7015):307-15
references.pmid: 15549092
references.citation: Nat Rev Cancer. 2008 Dec;8(12):915-28
references.pmid: 19029956
references.citation: FASEB J. 2001 Jun;15(8):1404-6
references.pmid: 11387238
references.citation: Hepatology. 2007 Jan;45(1):42-52
references.pmid: 17187432
references.citation: Hepatology. 2003 May;37(5):1105-13
references.pmid: 12717391
references.citation: Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11
references.pmid: 18929564
references.citation: Oncogene. 1989 Jun;4(6):715-24
references.pmid: 2543942
references.citation: J Hepatol. 2009 Oct;51(4):725-33
references.pmid: 19665249
references.citation: Cancer Lett. 2002 Feb 25;176(2):149-58
references.pmid: 11804742
references.citation: Cancer Res. 2008 Aug 15;68(16):6779-88
references.pmid: 18701503
references.citation: Nat Rev Cancer. 2006 Sep;6(9):674-87
references.pmid: 16929323
references.citation: J Clin Oncol. 2005 Sep 20;23(27):6657-63
references.pmid: 16170173
references.citation: Nature. 2009 Oct 1;461(7264):614-20
references.pmid: 19759537
references.citation: Oncogene. 2009 Feb 19;28(7):961-72
references.pmid: 19137011
references.citation: Genes Dev. 2008 Jun 1;22(11):1439-44
references.pmid: 18519636
references.citation: Nat Biotechnol. 2009 Mar;27(3):264-74
references.pmid: 19234449
references.citation: Science. 2002 Dec 6;298(5600):1911-2
references.pmid: 12471242
references.citation: Nat Rev Genet. 2008 May;9(5):329-40
references.pmid: 18398419
references.citation: Carcinogenesis. 2006 Apr;27(4):748-57
references.pmid: 16339184
references.citation: Hepatology. 2007 Aug;46(2):590-7
references.pmid: 17661407
references.citation: Hepatology. 1997 Apr;25(4):862-6
references.pmid: 9096589
references.citation: Cancer. 2005 Jan 15;103(2):307-12
references.pmid: 15593087
references.citation: Hepatology. 2007 May;45(5):1298-305
references.pmid: 17464972
references.citation: Oncogene. 2006 Jun 26;25(27):3787-800
references.pmid: 16799620
references.citation: J Clin Invest. 2006 Jun;116(6):1582-95
references.pmid: 16710476
references.citation: Mol Cancer Ther. 2007 Jan;6(1):1-12
references.pmid: 17237261
references.citation: JAMA. 2008 Jan 2;299(1):53-60
references.pmid: 18167406
references.citation: Nat Rev Genet. 2007 Jun;8(6):462-72
references.pmid: 17510666
references.citation: J Hepatol. 2008 May;48(5):858-79
references.pmid: 18314222
references.citation: Cancer. 2009 Oct 1;115(19):4576-85
references.pmid: 19551889
references.citation: Curr Opin Cell Biol. 2005 Dec;17(6):596-603
references.pmid: 16226444
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):741-54
references.pmid: 16915232
references.citation: Hum Mutat. 2003 Mar;21(3):201-16
references.pmid: 12619106
references.citation: Nat Genet. 1995 Dec;11(4):447-9
references.pmid: 7493029
references.citation: Cancer Cell. 2002 Apr;1(3):289-98
references.pmid: 12086865
references.citation: Cold Spring Harb Symp Quant Biol. 2005;70:251-61
references.pmid: 16869761
references.citation: Cancer Res. 1993 Apr 15;53(8):1719-23
references.pmid: 8467484
references.citation: J Med Invest. 2004 Aug;51(3-4):202-9
references.pmid: 15460907
references.citation: J Exp Clin Cancer Res. 1998 Mar;17(1):13-7
references.pmid: 9646228
references.citation: J Clin Invest. 2009 Mar;119(3):465-77
references.pmid: 19221438
references.citation: Nat Genet. 2003 Mar;33(3):396-400
references.pmid: 12567186
references.citation: Hepatology. 2002 Apr;35(4):834-42
references.pmid: 11915029
references.citation: Hepatology. 2005 Feb;41(2):307-14
references.pmid: 15660382
references.citation: Clin Cancer Res. 2008 Jun 15;14(12):3768-76
references.pmid: 18559595
references.citation: J Hepatol. 2010 Apr;52(4):550-9
references.pmid: 20206398
references.citation: Cancer. 2007 Sep 1;110(5):1059-67
references.pmid: 17623837
references.citation: Cancer Cell. 2009 Oct 6;16(4):295-308
references.pmid: 19800575
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17059-64
references.pmid: 16286660
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14771-6
references.pmid: 17785413
references.citation: Cold Spring Harb Symp Quant Biol. 2005;70:217-24
references.pmid: 16869757
references.citation: Cancer Res. 2004 Feb 15;64(4):1315-22
references.pmid: 14973059
references.citation: Nature. 2005 Aug 11;436(7052):807-11
references.pmid: 16094360
references.citation: N Engl J Med. 2008 Nov 6;359(19):1995-2004
references.pmid: 18923165
references.citation: Cancer Res. 2001 Jul 15;61(14):5389-95
references.pmid: 11454681
references.citation: Semin Liver Dis. 2007 Feb;27(1):55-76
references.pmid: 17295177
references.citation: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):143-8
references.pmid: 12518062
references.citation: Expert Rev Anticancer Ther. 2009 Feb;9(2):247-61
references.pmid: 19192962
references.citation: Nat Rev Cancer. 2006 Sep;6(9):729-34
references.pmid: 16915295
references.citation: Cell. 2002 Jan 25;108(2):135-44
references.pmid: 11832204
references.citation: Cancer Res. 2007 Mar 1;67(5):2081-8
references.pmid: 17332337
references.citation: Curr Opin Genet Dev. 2009 Feb;19(1):4-11
references.pmid: 19201597
references.citation: J Cell Biol. 2001 May 28;153(5):1023-34
references.pmid: 11381087
references.citation: Cell. 2009 Jun 12;137(6):1005-17
references.pmid: 19524505
references.citation: Int J Oncol. 2007 Aug;31(2):451-60
references.pmid: 17611703
references.citation: Cancer Cell. 2009 Oct 6;16(4):272-3
references.pmid: 19800570
references.citation: Science. 1994 May 27;264(5163):1317-9
references.pmid: 8191284
references.citation: Nature. 2008 Apr 3;452(7187):553-63
references.pmid: 18385729
references.citation: J Clin Invest. 2004 Jun;113(12):1774-83
references.pmid: 15199412
references.citation: Hepatology. 2008 Jun;47(6):2059-67
references.pmid: 18506891
references.citation: Differentiation. 2007 Nov;75(9):843-52
references.pmid: 17999742
references.citation: J Natl Cancer Inst. 2008 May 21;100(10):698-711
references.pmid: 18477802
references.citation: Cancer Cell. 2009 Feb 3;15(2):148-59
references.pmid: 19185849
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21
references.pmid: 15563600
references.citation: Cell. 2002 May 3;109(3):335-46
references.pmid: 12015983
references.citation: Cancer Res. 1996 Aug 15;56(16):3831-6
references.pmid: 8706031
references.citation: Nat Rev Drug Discov. 2008 Jun;7(6):504-16
references.pmid: 18511928
references.citation: Curr Biol. 2007 Dec 4;17(23):2054-60
references.pmid: 17980593
references.citation: Cell. 2006 Jun 30;125(7):1253-67
references.pmid: 16814713
references.citation: Cell. 1990 Jun 15;61(6):1137-46
references.pmid: 2350785
references.citation: Carcinogenesis. 2008 Jun;29(6):1087-91
references.pmid: 18495658
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):701-6
references.pmid: 9012848
references.citation: Cell Growth Differ. 1996 Nov;7(11):1513-23
references.pmid: 8930401
references.citation: Br J Surg. 2004 Oct;91(10):1354-60
references.pmid: 15376182
references.citation: Lancet. 2003 Dec 6;362(9399):1907-17
references.pmid: 14667750
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3389-94
references.pmid: 15728360
references.citation: Oncogene. 2000 Oct 19;19(44):5054-62
references.pmid: 11042693
references.citation: Science. 2007 Jul 6;317(5834):121-4
references.pmid: 17615358
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Cell. 2008 Nov 28;135(5):852-64
references.pmid: 19012953
references.citation: Science. 2008 Dec 5;322(5907):1490-4
references.pmid: 19056973
references.citation: Cancer Cell. 2008 Feb;13(2):153-66
references.pmid: 18242515